Equities

Astrotech Corp

Astrotech Corp

Actions
  • Price (EUR)8.35
  • Today's Change-0.20 / -2.34%
  • Shares traded-1.00
  • 1 Year change-15.23%
  • Beta--
Data delayed at least 15 minutes, as of May 16 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Astrotech Corporation is a spectrometry company, which launches, manages, and commercializes scalable companies based on its core technology. Its business units include Astrotech Technologies, Inc., 1st Detect Corporation, AgLAB, Inc., and BreathTech Corporation. Astrotech Technologies, Inc. owns and licenses the intellectual property related to the Astrotech Mass Spectrometer Technology (the AMS Technology). 1st Detect Corporation is a manufacturer of explosives trace detectors capable of also detecting narcotics. It was developed for use at airports, cargo and other secured facilities, and borders worldwide. 1st Detect holds an AMS Technology license from ATI for air passenger and cargo security applications. AgLAB, Inc. develops a series of mass spectrometers for use in the hemp and cannabis market with initial focus on optimizing yields in the distillation processes. BreathTech Corporation is developing a breath analysis tool to screen for volatile organic compound metabolites.

  • Revenue in USD (TTM)1.99m
  • Net income in USD-10.25m
  • Incorporated2017
  • Employees22.00
  • Location
    Astrotech Corp2105 DONLEY DR. SUITE 100Suite 240-9530AUSTIN 78758United StatesUSA
  • Phone+1 (512) 485-9530
  • Fax+1 (302) 655-5049
  • Websitehttps://www.astrotechcorp.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.